OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
February 11, 2014
EMA releases an update on its flu vaccine guidance.
February 07, 2014
Mylan Pharmaceuticals launches Hertraz, the world's first trastuzumab biosimilar in India.
February 05, 2014
BioOutsource will open a new Biosimilar Center of Excellence in Scotland.
February 02, 2014
PDA works with FDA to create pharmaceutical quality metrics.
CMOs may find opportunities in alternative expression services.
Experts discuss factors affecting drug delivery to the lungs and key considerations when developing inhalation formulations.
Automated sample handling, advanced glycan analysis, and specially designed columns are help speed up confirmation of the biosimilarity.
February 01, 2014
A changing biopharmaceutical industry is going beyond typically outsourced activities and is using CMOs for more challenging processes. Review the top 10 outsourcing trends.
January 31, 2014
PharmaCell enters an agreement purchase TiGenix therapy production facility.
I Holland announces service that predicts solutions for tablet sticking problems.